Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Myocardial Reperfusion Injury 2Cardiotoxicity 2Vomiting 1Uveal Melanoma 1Thrombosis 1Substance Withdrawal Syndrome 1Retinal Diseases 1Reperfusion Injury 1Pain, Postoperative 1Opioid-Related Disorders 1Nausea 1Melanoma 1Macular Degeneration 1Lymphoma, Follicular 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Choroid Diseases 1Breast Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × salicylhydroxamic acid × Clear all
NCT03166813 2022-06-08

Remote Ischaemic Preconditioning in Childhood Cancer

The University of Hong Kong

Phase NA Completed
68 enrolled

Neoplasms, Myocardial Reperfusion Injury, Cardiotoxicity

NCT00621660 2008-02-22

Acupuncture Versus Sham for Radiotherapy-Induced Emesis

University Hospital, Linkoeping

Phase NA Completed
237 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡